根据美国Frost和Sullivan公司最近的研究报告,预计今后6年期间美国的免疫治疗制剂市场每年将增长30%左右。这篇长达493页的研究报告说,1987年美国免疫治疗制剂市场总销售额约为15亿美元。估计到1993年将超过86亿美元。预计到1993年免疫抑制剂、皮质类固醇、癌化疗药和有关AIDS的化疗药的销售额均有明显增长,分别达到10亿以上、11亿和27亿美元。然而增长最大的将是一批用于免疫治疗的新产品:细胞因子,治疗性血浆取出 According to a recent study by Frost and Sullivan in the United States, it is expected that the U.S. market for immunotherapeutic agents will increase by about 30% annually over the next six years. The 493-page research report stated that in 1987 the US market for immunotherapeutic preparations had total sales of about $1.5 billion. It is estimated that by 1993 it will exceed 8.6 billion U.S. dollars. It is estimated that the sales of immunosuppressants, corticosteroids, cancer chemotherapy drugs, and AIDS-related chemotherapeutic drugs all increased significantly to 1993, reaching more than 1 billion, 1.1 billion, and 2.7 billion U.S. dollars, respectively. However, the biggest increase will be a new batch of products for immunotherapy: cytokines, therapeutic plasma removal